Sarcoma: open trials in Singapore

• NCT07261631

  Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

  Trial Treatment · Phase 1 · Novartis Pharmaceuticals

  Novartis Investigative Site, Singapore

  Registry updated 2026-10-09

• NCT06884618

  A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

  Trial Treatment · Phase 1 · Hoffmann-La Roche

  National Cancer Centre - 30 Hospital Blvd, Singapore

  Registry updated 2026-09-28

• NCT04094610

  A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  National University Hospital, Singapore · KK Women's and Children's Hospital, Singapore

  Registry updated 2026-09-25

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  National University Hospital, Singapore · National Cancer Center Singapore, Singapore

  Registry updated 2026-05-27

• NCT04986748

  Using QPOP to Predict Treatment for Sarcomas and Melanomas

  Research · National Cancer Centre, Singapore

  National Cancer Centre Singapore, Singapore

  Registry updated 2025-07-01

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error